Previous close | 5.10 |
Open | 2.95 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 131.00 |
Expiry date | 2024-05-31 |
Day's range | 2.95 - 5.10 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Merck has said it's in the market for deals of up to around $15 billion as it plans ways to deal with a loss of revenue from its aging cancer immunotherapy Keytruda.
Investing.com-- Merck&Company Inc (NYSE:MRK) is close to entering a $1.3 billion deal to buy Eyebiotech, granting the pharmaceutical giant entry into the rapidly growing eyecare market, the Wall Street Journal reported on Tuesday.
RAHWAY, N.J., May 28, 2024--Merck Announces Third-Quarter 2024 Dividend